Previous Play Slide ShowStop Slide Show Next
Carpentier-Edwards PERIMOUNT
Magna Ease Aortic Heart Valve

Where MAGNA hemodynamics
meets EASE of implantation.



The advanced Carpentier-Edwards PERIMOUNT Magna Ease aortic valve adds enhanced implantability to the unsurpassed hemodynamics1-7 of the Magna valve platform - setting the new standard for tissue valve performance.

Ease of implantation
  • Low profile eases insertion and aortotomy closure
  • Low stent base maximizes coronary ostia clearance
  • Sleek commissure posts ease insertion and enhance knot tying
  • Suture markers aid in valve orientation and suture placement
  • Contoured and compliant sewing ring provides an optimal anatomic fit
Proven superior hemodynamics
  • Industry-leading EOAs and low gradients documented in multiple published
    studies1-7
  • Based on a proven design with published hemodynamic stability up to 17 years post-implantation8
Designed for endurance
  • Built on the proven performance of PERIMOUNT aortic valves, with over 27 years of clinical experience9,10
  • The Carpentier-Edwards ThermaFix process* is the only anti-calcification technology designed to confront both major calcium binding sites


* No clinical data are available which evaluate the long-term impact of the Edwards Lifesciences tissue treatment in patients.


References
1. Dalmau MJ, González-Santos JM, López-Rodríguez J, et al. The Carpentier-Edwards Perimount Magna aortic xenograft: a new design with an improved hemodynamic performance. Int Cardiov Thorac Surg 2006;5:263-7.
2. Botzenhardt F, Eichinger WB, Guenzinger R, et al. Hemodynamic performance and incidence of patient-prosthesis mismatch of the complete supraannular Perimount Magna bioprosthesis in the aortic position. Thorac Cardiov Surg 2005;53:226-30.
3. Botzenhardt F, Eichinger WB, Bleiziffer S, et al. Hemodynamic comparison of bioprostheses for complete supra-annular position in patients with small aortic annulus. J Am Coll Cardiol 2005;45:2054-60.
4. Totaro P, Degno N, Zaidi A, et al. Carpentier-Edwards PERIMOUNT Magna bioprosthesis: a stented valve with stentless performance? J Thorac Cardiovasc Surg 2005;130:1668-74.
5. Dalmau MJ, González-Santos JM, López-Rodríguez J, et al. One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study. Int Cardiov Thorac Surg 2007;6:345-9.
6. Wagner IM, Eichinger WB, Bleiziffer S, et al. Influence of completely supra-annular placement of bioprostheses on exercise hemodynamics in patients with a small aortic annulus. J Thorac Cardiovasc Surg 2007;133:1234-41.
7. Borger MA, Nette AF, Maganti M, et al. Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison. Ann Thorac Surg 2007;83:2054-9.
8. Banbury MK, Cosgrove DM, Thomas JD, et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002;73:1460-5.
9. Carpentier-Edwards PERIMOUNT aortic pericardial bioprosthesis 20-year results. Data on file at Edwards Lifesciences, 2003.
10. Aupart MR, Mirza A, Meurisse YA, et al. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1,133 patients. J Heart Valve Dis 2006;15:768-76.
CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.